Dr. Pradip Nirbhavane | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Amity University, India

Author Profile

Early Academic Pursuits

Dr. Pradip Nirbhavane embarked on an illustrious academic journey starting with a Bachelor of Pharmacy from the University of Pune, where he demonstrated exceptional competence with an average of 60.95%. His pursuit of excellence continued at NIPER, SAS Nagar, where he earned an M.S. (Pharm) degree with a notable 7.1 CGPA. This solid academic foundation paved the way for his significant contributions in the field of pharmaceuticals.

Professional Endeavors

His professional journey began as a Senior Research Fellow at Lifecare Innovations Pvt Ltd, where he contributed for nearly three years. Subsequently, he joined Intas Pharmaceuticals Ltd as an Assistant Manager, accumulating valuable industry experience for over two years. Currently, he serves as an Assistant Professor at Amity University, Gurgaon, where he imparts knowledge and fosters academic growth.

Contributions and Research Focus

His research focus encompasses nanotechnology and drug delivery, with a particular emphasis on topical, oral, and parenteral drug administration. His groundbreaking work includes novel discoveries and advancements in treating conditions like Onychomycosis and uveitis, as evidenced by his publications in esteemed journals such as Advanced Drug Delivery Reviews, International Ophthalmology, and Colloids and Surfaces B: Biointerfaces.

Accolades and Recognition

Throughout his career, Dr. Nirbhavane has been honored with prestigious awards, including the "Korean Ginseng Society-International Young Scientist" award and the "University of Birmingham India Institute Fellowship." These accolades underscore his exceptional contributions and recognition within the global scientific community.

Impact and Influence

His research has made a significant impact on the pharmaceutical landscape, particularly in enhancing drug bioavailability, targeted delivery, and therapeutic efficacy. His work on lipid nanocarriers and nanostructured formulations has opened new avenues for more effective and personalized treatments across various medical conditions.

Legacy and Future Contributions

With a legacy of impactful research and academic excellence, His continues to inspire future generations of pharmaceutical scientists. His dedication to quality research, innovative methodologies, and collaborative initiatives ensures a promising future characterized by advancements in drug delivery systems and improved patient outcomes.

Notable Publications 

Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder (s)

Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1

Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics

A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne

Quality by design (QbD)-based development and optimization of a simple, robust RP-HPLC method for the estimation of methotrexate

Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity

Nanolipoidal α-terpineol modulates quorum sensing regulated virulence and biofilm formation in Pseudomonas aeruginosa

Lipid nanocarrier-mediated drug delivery system to enhance the oral bioavailability of rifabutin

Nano-constructed carriers loaded with antioxidant: Boon for cardiovascular system



Pradip Nirbhavane | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

You May Also Like